Nebula Genomics aims to launch a genomics platform that will let users securely monetise their personal data and gain medical insights.

Nebula Genomics, a new US-based genomics spinout of Harvard University, is set to launch a platform for users to earn cryptocurrency in exchange for letting pharmaceutical firms use their data, according to Technology Review. The company has released a white paper into the technology, which will offer affordable genome sequencing that can establish a person’s…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.